Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3006

Actual shortage: 229 (8%)
Anticipated shortage: 21 (1%)
Avoided shortage: 9 (0%)
Resolved: 2747 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LITHIUM CARBONATE 150MG CAPSULE Actual shortage 2024-04-19 2024-04-19 225802
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-19 2024-04-19 225799
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Actual shortage 2024-04-19 2024-04-19 225796
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225793
APO-TADALAFIL 10MG TABLET Actual shortage 2024-04-19 2024-04-19 225790
APO-TADALAFIL PAH 20MG TABLET Actual shortage 2024-04-19 2024-04-19 225785
APO-WARFARIN 1MG TABLET Actual shortage 2024-04-19 2024-04-19 225782
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225779
APO-DASATINIB 70MG TABLET Actual shortage 2024-04-19 2024-04-19 225776
APO-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-19 2024-04-19 225773
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225770
APO-TRIMEBUTINE 100MG TABLET Actual shortage 2024-04-19 2024-04-19 225767
APO-VARENICLINE 1MG TABLET Actual shortage 2024-04-19 2024-04-19 225764
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-04-19 2024-04-19 225761
APO-LORAZEPAM 0.5MG TABLET Actual shortage 2024-04-12 2024-04-19 225014
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2024-04-12 2024-04-19 225008
APO-TERBINAFINE 250MG TABLET Actual shortage 2024-04-12 2024-04-19 225005
APO-PRAMIPEXOLE 0.25MG TABLET Actual shortage 2024-04-12 2024-04-19 224993
APO-GLICLAZIDE 80MG TABLET Actual shortage 2024-04-05 2024-04-19 224583
APO-PRAMIPEXOLE 1.5MG TABLET Actual shortage 2024-03-22 2024-04-19 223055

Showing 1 to 20 of 3006

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO-CEPHALEX 250MG TABLET Discontinued 2018-09-07 2019-02-21 60370
APO-CEFPROZIL 250MG TABLET Discontinued 2019-01-04 2019-02-21 71195
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-02-21 70802
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2018-09-07 2019-02-13 60521
APO-CITALOPRAM 20MG TABLET Discontinued 2018-09-07 2019-02-13 60393
APO-ATORVASTATIN 20MG TABLET Discontinued 2018-09-07 2019-02-13 60279

Showing 81 to 100 of 356